全文获取类型
收费全文 | 855945篇 |
免费 | 79089篇 |
国内免费 | 56657篇 |
专业分类
耳鼻咽喉 | 7031篇 |
儿科学 | 10176篇 |
妇产科学 | 10436篇 |
基础医学 | 101314篇 |
口腔科学 | 14752篇 |
临床医学 | 116020篇 |
内科学 | 112739篇 |
皮肤病学 | 8709篇 |
神经病学 | 42411篇 |
特种医学 | 31412篇 |
外国民族医学 | 456篇 |
外科学 | 78797篇 |
综合类 | 157624篇 |
现状与发展 | 184篇 |
一般理论 | 83篇 |
预防医学 | 59065篇 |
眼科学 | 24300篇 |
药学 | 94525篇 |
872篇 | |
中国医学 | 55787篇 |
肿瘤学 | 64998篇 |
出版年
2024年 | 1774篇 |
2023年 | 10540篇 |
2022年 | 20526篇 |
2021年 | 38842篇 |
2020年 | 30216篇 |
2019年 | 25229篇 |
2018年 | 27045篇 |
2017年 | 25990篇 |
2016年 | 23793篇 |
2015年 | 36426篇 |
2014年 | 45912篇 |
2013年 | 42696篇 |
2012年 | 62493篇 |
2011年 | 70328篇 |
2010年 | 47534篇 |
2009年 | 38689篇 |
2008年 | 48256篇 |
2007年 | 48497篇 |
2006年 | 47391篇 |
2005年 | 45543篇 |
2004年 | 30499篇 |
2003年 | 28989篇 |
2002年 | 24566篇 |
2001年 | 21851篇 |
2000年 | 21738篇 |
1999年 | 21886篇 |
1998年 | 13735篇 |
1997年 | 13596篇 |
1996年 | 10636篇 |
1995年 | 10089篇 |
1994年 | 8455篇 |
1993年 | 5634篇 |
1992年 | 7062篇 |
1991年 | 6033篇 |
1990年 | 5109篇 |
1989年 | 4385篇 |
1988年 | 3856篇 |
1987年 | 3215篇 |
1986年 | 2726篇 |
1985年 | 2133篇 |
1984年 | 1367篇 |
1983年 | 1002篇 |
1982年 | 660篇 |
1981年 | 610篇 |
1980年 | 478篇 |
1979年 | 556篇 |
1978年 | 321篇 |
1977年 | 322篇 |
1976年 | 257篇 |
1974年 | 253篇 |
排序方式: 共有10000条查询结果,搜索用时 333 毫秒
81.
Yan Gao Shi-Feng Chu Zhao Zhang Qi-Di Ai Cong-Yuan Xia Hui-Yong Huang 《Journal of Asian natural products research》2019,21(8):782-797
Inappropriate use of acetaminophen (APAP) can lead to morbidity and mortality secondary to hepatic necrosis. Ginsenoside Rg1 is a major active ingredient in processed Panax ginseng, which is proved to elicit biological effects. We hypothesized the beneficial effect of Rg1 on APAP-mediated hepatotoxicity was through Nrf2/ARE pathway. The study was conducted in cells and mice, comparing the actions of Rg1. Rg1 significantly improved cell survival rates and promoted the expression of antioxidant proteins. Meanwhile, Rg1 reduced the excessive ROS and the occurrence of cell apoptosis, which were related to Nrf2/ARE pathway. Expression of Nrf2 has a certain cell specificity.
82.
83.
Liam Masterson James Howard Jazmina Gonzalez-Cruz Christopher Jackson Catherine Barnett Lewis Overton Howard Liu Rahul Ladwa Fiona Simpson Margie McGrath Ben Wallwork Terry Jones Christian Ottensmeier Melvin L.K. Chua Chris Perry Rajiv Khanna Benedict Panizza Sandro Porceddu Matt Lechner 《International journal of cancer. Journal international du cancer》2020,146(8):2305-2314
Now is an exciting era of development in immunotherapy checkpoint inhibitors and their effect on the treatment of NPC. While the general prognosis of R/M disease is poor, immunotherapy offers some promise in a malignancy associated with EBV and characterized by a peritumoural immune infiltrate. Our study aims to review past and on-going clinical trials of monoclonal antibody therapies against the checkpoint inhibitors (e.g. PD1 and CTLA-4), in R/M NPC. All randomized and nonrandomized controlled trials involving immune checkpoint inhibitor interventions for treatment of NPC were included in the study. We utilized a validated “risk of bias” tool to assess study quality. Four separate Phase I–II trials report the potential of PD1 inhibitor treatment for patients with NPC. Within the observed groups, camrelizumab combined with chemotherapy achieved an objective response in 91% of patients as first-line treatment for metastatic NPC (PFS 68% at 1-year) but this was associated with a high rate of grade >3 adverse events (87%; CTCAE version 4.03). The remaining three studies focused on recurrent NPC disease in patients who had received at least one line of prior chemotherapy. Within this group, camrelizumab monotherapy achieved an objective response in 34% of patients (PFS 27% at 1-year; range across all three studies 20.5–34%). No NPC trial has yet reported on specific outcomes for non-PD1 checkpoint inhibitors but 11 on-going studies include alternative targets (e.g. PD-L1/CTLA-4) as combination or monotherapy treatments. In considering checkpoint immunotherapies for NPC, initial results show promise for anti-PD1 interventions. Further phase I–III trials are in progress to clarify clinical outcomes, fully determine safety profiles, and optimize drug combinations and administration schedules. 相似文献
84.
姜毅 陆小霞 金润铭 郑跃杰 徐保平 谢正德 刘智胜 林丽开 尚云晓 舒赛男 白燕 陆敏 卢根 邓继岿 罗万军 熊莉娟 刘苗 崔玉霞 叶乐平 高立伟 王永炎 王雪峰 李家福 王天有 蒋荣猛 李兴旺 赵东赤 邵剑波 杨永弘 申昆玲 《中华实用儿科临床杂志》2020,(2):143-150
自2019年12月新型冠状病毒感染暴发以来,我国政府采取了严格的防控措施,国内疫情已得到初步控制,但形势依然严峻,境外多个国家也相继出现疫情。根据世界卫生组织的报告:截至2020年3月5日,全球共报告95333例确诊病例(其中我国累计报告确诊病例80565例),85个国家有确诊病例报告,中国将面临输入性病例的传播风险,这为防治我国儿童的疾病疫情提出了新的挑战[1]。在这次疫情中,与成人病例相比,儿童病例相对较少、症状轻、预后较好。目前国内病例数据显示,18岁以下儿童占所有报告病例的2.4%,尚无死亡病例报告[2]。 相似文献
85.
86.
Feng Wang Dachuan Wang Bingyi Tan Jun Dong Rongjie Feng Zenong Yuan Naiguo Wang 《Medicine》2015,94(39)
The present study aimed at examining the curative effect of modified posterior operation on treatment of Kümmell''s disease.About 30 patients of Kümmell''s disease with complete image and clinical data treated during June 2004 to July 2013 were conducted with anterior and posterior approaches, respectively. Kyphotic Cobb angle, fractured vertebra wedge angle, and the anterior and posterior heights of fractured vertebra were all measured through x-ray before and after operation, and the pain visual analog scale (VAS) was determined for evaluating the effect of operations. The injury and restoration of neurological function were assessed using Frankel classification.Patients in group A were treated with anterior operation, whereas group B was posterior operation. Postoperatively, VAS score, kyphotic Cobb angle, anterior vertebra height, and pathologic vertebra wedge angle were all significantly improved in patients with Kümmell''s disease receiving modified posterior operation (group B). Similar results were also observed in patients with anterior operation. The improvement of VAS and correction rate of kyphotic Cobb angle indicated equivalent effects of posterior and anterior operations. Meanwhile, alleviated neurological function damage was observed in 2 groups. Relevant factor analysis illustrated that there was no significant correlation of the severity and improvement rate of pain symptoms with age, medical history, anterior and posterior vertebra heights, kyphotic Cobb angle, and pathological vertebra wedge angle.Compared with traditional anterior approach, modified posterior operation, adopting transpedicular vertebral body grafting combined with vertebral pedicle screw fixation, could produce equivalent effects on kyphosis correction, pain relief, and improvement of neurological function in patients with Kümmell''s disease. 相似文献
87.
目的探讨脑卒中患者急性应激障碍发生现状及影响因素。方法采用斯坦福急性应激反应问卷对349例脑卒中住院患者进行调查。结果共163例(46.70%)患者发生急性应激障碍;Logistic回归分析结果显示,患者性格、是否存在偏瘫及是否吞咽功能障碍是脑卒中患者发生急性应激障碍的主要影响因素(P0.05,P0.01)。结论脑卒中患者急性应激障碍发生率较高,内向性格及存在偏瘫和吞咽功能障碍的患者更容易发生急性应激障碍。医护人员应及时为高危患者提供个体化治疗及预见性护理,防止脑卒中患者发生急性应激障碍。 相似文献
88.
良性前列腺增生(BPH)是老年男性常见的泌尿系统疾病,其发病与前列腺慢性炎症之间存在显著相关。感染因子、尿液返流、代谢综合征、衰老过程和自身免疫应答在内的几种刺激,通过相应分子途径引起前列腺免疫细胞的组织定位和组成成分发生广泛改变,从而导致免疫系统失调,之后引发的组织损伤和缓慢愈合,导致了BPH发生和进展。本文通过总结良性前列腺增生与前列腺慢性炎症的相关性的临床研究结果,前列腺免疫细胞在病理生理机制层面与前两者之间的内在联系,以及抗炎药物对BPH-LUTS的干预作用,以其为BPH-LUTS的药物研发提供参考。 相似文献
89.
90.
目的探讨人工弓状线切开技术在变异弓状线病例腹腔镜全腹膜外腹股沟疝修补术(TEP)应用的可靠性、安全性和有效性。
方法回顾性分析2016年7月至2019年8月广东医科大学茶山医院施行TEP的60例弓状线变异患者资料,在脐与耻骨联合连线中点人为切开腹直肌后鞘及其后面的腹横筋膜创建一条人工弓状线,并对其后面的腹膜前间隙进分离。影像记录弓状线的形态和手术步骤。
结果低位弓状线50例(83.3%),位于脐下8~12 cm,表现为不完整的腹直肌后鞘,向下呈逐渐变薄、变少的散在纤维。无弓状线10例(16.7%),有完整的腹直肌后鞘并一直延伸至耻骨。以人工弓状线为界分为两个层面,前面的是腹直肌后间隙,后面是腹膜前间隙,位于腹横筋膜(含有后鞘)与腹膜前筋膜浅层之间,是TEP理想的分离层面,沿此间隙向下分离与Retzius间隙相连,然后向外分离Bogros间隙。本组平均手术时间(130±15)min,术中腹膜损伤率8.3%(5/60)。术后发生血肿3例,血清肿2例,皮下气肿3例,无慢性疼痛病例。术后平均随访25个月,无复发病例。
结论人工弓状线切开技术在低位和无弓状线患者的TEP手术中安全有效、简单可靠,值得推广。 相似文献